Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

被引:0
作者
Mohammad Elahimanesh
Nafiseh Shokri
Elmira Mahdinia
Payam Mohammadi
Najmeh Parvaz
Mohammad Najafi
机构
[1] Iran University of Medical Sciences,Clinical Biochemistry Department, Faculty of Medical Sciences
[2] Iran University of Medical Sciences,Cellular and Molecular Research Center
来源
Scientific Reports | / 14卷
关键词
STEMI; NSTEMI; Gene profile; Gene network;
D O I
暂无
中图分类号
学科分类号
摘要
The ST-elevation Myocardial Infarction (STEMI) and Non-ST-elevation Myocardial Infarction (NSTEMI) might occur because of coronary artery stenosis. The gene biomarkers apply to the clinical diagnosis and therapeutic decisions in Myocardial Infarction. The aim of this study was to introduce, enrich and estimate timely the blood gene profiles based on the high-throughput data for the molecular distinction of STEMI and NSTEMI. The text mining data (50 genes) annotated with DisGeNET data (144 genes) were merged with the GEO gene expression data (5 datasets) using R software. Then, the STEMI and NSTEMI networks were primarily created using the STRING server, and improved using the Cytoscape software. The high-score genes were enriched using the KEGG signaling pathways and Gene Ontology (GO). Furthermore, the genes were categorized to determine the NSTEMI and STEMI gene profiles. The time cut-off points were identified statistically by monitoring the gene profiles up to 30 days after Myocardial Infarction (MI). The gene heatmaps were clearly created for the STEMI (high-fold genes 69, low-fold genes 45) and NSTEMI (high-fold genes 68, low-fold genes 36). The STEMI and NSTEMI networks suggested the high-score gene profiles. Furthermore, the gene enrichment suggested the different biological conditions for STEMI and NSTEMI. The time cut-off points for the NSTEMI (4 genes) and STEMI (13 genes) gene profiles were established up to three days after Myocardial Infarction. The study showed the different pathophysiologic conditions for STEMI and NSTEMI. Furthermore, the high-score gene profiles are suggested to measure up to 3 days after MI to distinguish the STEMI and NSTEMI.
引用
收藏
相关论文
共 1456 条
[51]  
Seljeflot I(2016)Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution J. Mol. Cell Cardiol. 100 765-1834
[52]  
Bøhmer E(2013)Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance Diabetes. 62 H1104-16
[53]  
Arnesen H(2021)Plasma metabolites alert patients with chest pain to occurrence of myocardial infarction Front Cardiovasc. Med. 8 12997-673
[54]  
Halvorsen S(2022)Bioinformatics analysis to identify potential biomarkers and therapeutic targets for ST-segment-elevation myocardial infarction-related ischemic stroke Front Neurol. 13 18-58
[55]  
Gerede DM(2015)GW26-e0264 Microarray analysis of differential gene expression profile in the peripheral blood cells of the patients with myocardial infarction J. Am. College Cardiol. 66 1-404
[56]  
Güleç S(2018)Involvement of JNK1/2-NF-κBp65 in the regulation of HMGB2 in myocardial ischemia/reperfusion-induced apoptosis in human AC16 cardiomyocytes Biomed. Pharmacother. 106 384-326
[57]  
Kiliçkap M(2018)Genetic variants in HSD17B3, SMAD3, and IPO11 impact circulating lipids in response to fenofibrate in individuals with type 2 diabetes Clin. Pharmacol. Ther. 103 1148-23
[58]  
Kaya CT(2018)Screening genes associated with elevated neutrophil-to-lymphocyte ratio in chronic heart failure Mol. Med. Rep. 18 379-525
[59]  
Vurgun VK(2009)Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI Clin. Res. Cardiol. 98 82-203
[60]  
Özcan ÖU(2013)Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted? Am. J. Physiol. Heart Circ. Physiol. 305 3764-2724